Pepdox
Studies
Peptides
Calculator
Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes. | Pepdox
Home
/
Search
/
PMID 38157134
Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes.
Journal of endocrinological investigation
2024
PMID: 38157134
View on PubMed
DOI: 10.1007/s40618-023-02290-2
Semaglutide
Authors
Basolo, A; Fierabracci, P; Salvetti, G; Santini, F
Keywords
Cardiovascular outcomes
Obesity
Semaglutide